Practice
Featured experience
Qorvo $22 billion combination with Skyworks Solutions
We are advising Qorvo on the transaction
Goldman Sachs $9.5 billion sale of Boyd Thermal and related business separations
We are advising Goldman Sachs Merchant Banking Division and its portfolio company Boyd on the transactions
AkzoNobel $25 billion merger of equals with Axalta Coating Systems
We are advising AkzoNobel on the transaction
REV Group $9 billion merger with Terex
We are advising REV Group on the transaction
Davis Polk Advises Grupo Financiero Santander México on Its Merger with and into Banco Santander (México)
Davis Polk advised Grupo Financiero Santander México, S.A.B. de C.V. (“Grupo Financiero Santander México”) and Banco…
Varian Medical Systems Acquires Sirtex Medical
Davis Polk is advising J.P. Morgan Securities LLC as financial adviser to Varian Medical Systems, Inc. in connection with…
Expro chapter 11 plan of reorganization
Davis Polk advised an ad hoc group of prepetition senior secured lenders in connection with the successful chapter 11…
A.P. Moller – Maersk joint venture with IBM to commercialize blockchain platform
Davis Polk is advising A.P. Moller – Maersk on its formation of a joint venture with IBM. The new joint venture will…
Ferrero $2.8 billion acquisition of Nestlé’s U.S. confectionary business
Davis Polk is advising The Ferrero Group on its $2.8 billion acquisition of Nestlé’s U.S. confectionary business. The…
SS&C Technologies $5.4 billion acquisition of DST Systems
Davis Polk is advising SS&C Technologies Holdings, Inc. on its approximately $5.4 billion acquisition of DST…
Davis Polk Advises Masco Corporation on Its Acquisition of Kichler Lighting
Davis Polk is advising Masco Corporation in connection with its acquisition of The L.D. Kichler Co. announced on January 8,…
Davis Polk Advises CEO and Co-Founder of Schmidt’s Naturals on Its Acquisition by Unilever
Davis Polk advised the CEO and co-founder of Schmidt’s Naturals in connection with the acquisition of Schmidt’s Naturals by…
Davis Polk Advises TiGenix on Its Acquisition by Takeda
Davis Polk is advising TiGenix in connection with its entry into an offer and support agreement with Takeda Pharmaceutical…
Davis Polk Advises OneMain’s Transaction Committee on the $1.4 Billion Sale of OneMain Shares by Fortress to an Investor Group Led by Apollo and Värde
Davis Polk advised the Transaction Committee of the Board of Directors of OneMain Holdings, Inc. in connection with the $1.4…